Elekta (OTCMKTS:EKTAY) Shares Gap Up – What’s Next?

Elekta AB (OTCMKTS:EKTAY)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $5.0150, but opened at $5.21. Elekta shares last traded at $5.21, with a volume of 1,007 shares changing hands.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 28th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Elekta has a consensus rating of “Hold”.

Elekta Price Performance

The company has a 50 day moving average price of $5.26 and a 200 day moving average price of $5.62. The firm has a market cap of $1.92 billion, a PE ratio of -43.50 and a beta of 1.05. The company has a current ratio of 0.87, a quick ratio of 0.68 and a debt-to-equity ratio of 0.47.

Elekta (OTCMKTS:EKTAY) last released its quarterly earnings data on Thursday, August 27th. The company reported $0.07 earnings per share for the quarter. The firm had revenue of $372.30 million during the quarter. Elekta had a positive return on equity of 13.31% and a negative net margin of 2.38%. On average, sell-side analysts expect that Elekta AB will post 0.43 EPS for the current year.

Elekta Company Profile

Elekta AB is a Sweden-based medical technology company focused on radiation oncology and precision treatment solutions. The company develops and supplies systems used to diagnose, plan and deliver treatments for cancer and other conditions affecting the brain and nervous system.

Its product portfolio includes linear accelerators for external-beam radiotherapy, stereotactic radiosurgery systems such as Leksell Gamma Knife, brachytherapy equipment and treatment-planning, oncology information and workflow software.